NASDAQ:MBOTMicrobot Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Microbot Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.63 +0.05 (+0.76 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range$6.51Now: $6.63▼$6.7950-Day Range$6.50MA: $7.07▼$7.5752-Week Range$4.30Now: $6.63▼$20.15Volume114,700 shsAverage Volume118,180 shsMarket Capitalization$47.07 millionP/E RatioN/ADividend YieldN/ABeta4.29 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingMicrobot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $19.00, Microbot Medical has a potential upside of 186.6% from its current price of $6.63.Amount of Analyst CoverageMicrobot Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 2.8 Community Rank Outperform VotesMicrobot Medical has received 341 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMicrobot Medical has received 268 “underperform” votes. (Add your “underperform” vote.)Community SentimentMicrobot Medical has received 55.99% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote “Outperform” if you believe MBOT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 14.47% of the stock of Microbot Medical is held by insiders.Percentage Held by InstitutionsOnly 10.73% of the stock of Microbot Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Microbot Medical are expected to decrease in the coming year, from ($1.15) to ($1.30) per share.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 1.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.26 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MBOT Previous Symbol CUSIPN/A CIK883975 Webwww.microbotmedical.com Phone781-875-3605Debt Debt-to-Equity Ratio0.02 Current Ratio32.47 Quick Ratio32.47Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$5.02 per share Price / Book1.32Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-7,250,000.00 Net MarginsN/A Return on Equity-39.63% Return on Assets-32.53%Miscellaneous Employees9 Outstanding Shares7,100,000Market Cap$47.07 million Next Earnings Date8/12/2020 (Estimated) OptionableNot Optionable NASDAQ:MBOT Rates by TradingView Receive MBOT News and Ratings via Email Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions How has Microbot Medical's stock been impacted by COVID-19 (Coronavirus)? Microbot Medical's stock was trading at $6.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MBOT stock has increased by 3.9% and is now trading at $6.63. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Microbot Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Microbot Medical. When is Microbot Medical's next earnings date? Microbot Medical is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Microbot Medical. How were Microbot Medical's earnings last quarter? Microbot Medical Inc (NASDAQ:MBOT) posted its earnings results on Friday, May, 15th. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.28) by $0.03. View Microbot Medical's earnings history. When did Microbot Medical's stock split? How did Microbot Medical's stock split work? Microbot Medical's stock reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split. What price target have analysts set for MBOT? 1 equities research analysts have issued 1-year price objectives for Microbot Medical's stock. Their forecasts range from $19.00 to $19.00. On average, they anticipate Microbot Medical's share price to reach $19.00 in the next twelve months. This suggests a possible upside of 186.6% from the stock's current price. View analysts' price targets for Microbot Medical. Has Microbot Medical been receiving favorable news coverage? News headlines about MBOT stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Microbot Medical earned a coverage optimism score of 1.3 on InfoTrie's scale. They also gave media coverage about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about Microbot Medical. Who are some of Microbot Medical's key competitors? Some companies that are related to Microbot Medical include LogicBio Therapeutics (LOGC), Axcella Health (AXLA), Surface Oncology (SURF), Verona Pharma (TARA), Cidara Therapeutics (CDTX), Applied Genetic Technologies (AGTC), Erytech Pharma (ERYP), Solid Biosciences (SLDB), X4 Pharmaceuticals (XFOR), Outlook Therapeutics (OTLK), Ayala Pharmaceuticals (AYLA), La Jolla Pharmaceutical (LJPC), Champions Oncology (CSBR), Gamida Cell (GMDA) and Creative Realities (CRDF). View all competitors. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Novavax (NVAX), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Athersys (ATHX), NovaBay Pharmaceuticals (NBY), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU) and Sarepta Therapeutics (SRPT). Who are Microbot Medical's key executives? Microbot Medical's management team includes the following people: Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 46)Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 50)Dr. Simon Sharon, CTO & Chairman of Scientific Advisory BoardProf. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 67)Dr. Eric C. Leuthardt, Scientific Director & Member of Scientific Advisory Board What is Microbot Medical's stock symbol? Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT." How do I buy shares of Microbot Medical? Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Microbot Medical's stock price today? One share of MBOT stock can currently be purchased for approximately $6.63. How big of a company is Microbot Medical? Microbot Medical has a market capitalization of $47.07 million. Microbot Medical employs 9 workers across the globe. What is Microbot Medical's official website? The official website for Microbot Medical is www.microbotmedical.com. How can I contact Microbot Medical? Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected] This page was last updated on 7/12/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
